Stocks
Arcturus Therapeutics Holdings (ARCT) EBITDA margin US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -752.6% | -1 621% | 5.67% | -44.2% | -0.76% | -50.8% | ||
| Changes by years, y/y, % | -630pp | -869pp | +1 627pp | -50pp | +43pp | -64.5% | |||
Arcturus Therapeutics Holdings. EBITDA margin, %
Arcturus Therapeutics Holdings. EBITDA margin, changes, pp
Arcturus Therapeutics Holdings (ARCT) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2023Q4 | 2024Q1 | LTM ? | |||
| EBITDA margin, % | ? | -537.2% | -44.5% | -44.5% | -36.5% | -78.2% | -50.8% | |
| Changes by years, y/y, % | -457pp | +224pp | -123pp | -115pp | -55pp | |||
| Changes by quarters, q/q, % | -514pp | +493pp | 0pp | +8pp | -42pp | |||
